TARDBP and amyotrophic lateral sclerosis: Indeed, recent studies suggest that AMPK cellular activity is dysregulated in the context of ALS pathology, but evidence to support the signaling mechanisms involved is unfortunately insufficient and limited to TDP-43 and SOD1 pathologies.